OurCrowd (Investment in Diagnotic) L.P.
Raised
$38K
Investors
2
Min Invest
$10,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
OurCrowd (Investment in Diagnotic) L.P. is a single-deal investment vehicle formed as a BVI limited partnership, filed under Form D exemption 506(b), raising $38K from 2 investors with a $10K minimum investment. The filing lists Jonathan Medved, Andrew Kaye, Caleb Chill, and Robert Citron as executive officers/directors, consistent with the OurCrowd venture investing platform, though no parent platform record was matched in this database yet.
This is a small, single-deal SPV structure typical of venture syndication platforms that pool capital into a target company via a dedicated LP vehicle, using the 506(b) exemption common for non-advertised private placements. A $10K minimum and $38K total raise across 2 investors reflects a narrow, likely early or limited-participation closing rather than a broadly marketed fund offering.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
2
lapsed
Fund family Part of the OurCrowd family: 475 vehicles across 41 generations · full family and the filing behind each link in the terminal
Investor
- The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
- 2 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Jonathan Medved
Executive Officer, Director · Jerusalem, L3
Andrew Kaye
Executive Officer, Director · Jerusalem, L3
Caleb Chill
Executive Officer · Jerusalem, L3
Robert Citron
Executive Officer · Jerusalem, L3
Questions About OurCrowd (Investment in Diagnotic) L.P.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is OurCrowd (Investment in Diagnotic) L.P.?
OurCrowd (Investment in Diagnotic) L.P. is a Virgin Islands, British limited partnership that filed a Form D with the SEC on May 31, 2022 as a venture capital fund. The filing claims Rule 506(b) for an offering of pooled investment fund interests.
Is OurCrowd (Investment in Diagnotic) L.P. legit?
AltStreet does not rate legitimacy; it reports the public record. OurCrowd (Investment in Diagnotic) L.P. filed a Form D with the SEC on May 31, 2022 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $38,000 sold to 2 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is OurCrowd (Investment in Diagnotic) L.P. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that OurCrowd (Investment in Diagnotic) L.P. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has OurCrowd (Investment in Diagnotic) L.P. raised?
OurCrowd (Investment in Diagnotic) L.P. reported $38,000 sold from 2 investors of a $500,000 total offering as of the Form D filed May 31, 2022.
Who can invest in OurCrowd (Investment in Diagnotic) L.P.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.
What is the minimum investment in OurCrowd (Investment in Diagnotic) L.P.?
The Form D lists $10,000 as the minimum investment accepted from any outside investor as of May 31, 2022. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling OurCrowd (Investment in Diagnotic) L.P. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind OurCrowd (Investment in Diagnotic) L.P.?
The Form D lists 4 related persons: Jonathan Medved, executive officer, director (Mr. Medved is Managing Partner of the General Partner, OurCrowd International General Partner, LP); Andrew Kaye, executive officer, director (Mr. Kaye is Managing Partner of the General Partner); Caleb Chill, executive officer (Mr. Chill is Partner and General Counsel of the General Partner); Robert Citron, executive officer (Mr. Citron is CFO of the General Partner). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is OurCrowd (Investment in Diagnotic) L.P. located?
The issuer's address on its SEC filings is Derech Hebron 28, Jerusalem, Israel 9108001. Its phone number of record is 00972-636-9300. It is organized under the laws of Virgin Islands, British.
How long is the OurCrowd (Investment in Diagnotic) L.P. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is OurCrowd (Investment in Diagnotic) L.P.?
The Form D reports a revenue range of No Revenues.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.